These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1843102)

  • 21. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group.
    Rutqvist LE; Mattsson A
    J Natl Cancer Inst; 1993 Sep; 85(17):1398-406. PubMed ID: 8350363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
    Baum M; Buzdar A; Cuzick J; Forbes J; Houghton J; Howell A; Sahmoud T;
    Cancer; 2003 Nov; 98(9):1802-10. PubMed ID: 14584060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of 5 years of postoperative adjuvant tamoxifen therapy for Korean women with breast cancer: retrospective cohort study of the Korean breast cancer society database.
    Yang JJ; Park SK; Cho LY; Han W; Park B; Kim H; Lee KS; Hahn SK; Cho SI; Ahn SH; Noh DY;
    Clin Ther; 2010 Jun; 32(6):1122-38. PubMed ID: 20637966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy of node-negative breast cancer.
    Hall PD; Lesher BA; Hall RK
    Ann Pharmacother; 1995 Mar; 29(3):289-98. PubMed ID: 7606076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of adjuvant endocrine therapy in the management of operable breast cancer].
    Miura S; Yoshida M; Murai H
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3203-13. PubMed ID: 3058042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.
    Rocchi A; Verma S
    Support Care Cancer; 2006 Sep; 14(9):917-27. PubMed ID: 16596419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women.
    Smith TJ; Hillner BE
    J Clin Oncol; 1993 Apr; 11(4):771-6. PubMed ID: 8478670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-benefit analysis of anastrazol and tamoxifen in adjuvant treatment of hormone receptor-positive, post-menopausal breast cancer].
    Gamboa O; Díaz S; Chicaíza L; García M
    Biomedica; 2010; 30(1):46-55. PubMed ID: 20890549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.
    Bryson HM; Plosker GL
    Pharmacoeconomics; 1993 Jul; 4(1):40-66. PubMed ID: 10146967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.
    Buzdar AU;
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):399-403. PubMed ID: 14623537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
    Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
    J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.
    Stewart HJ; Forrest AP; Everington D; McDonald CC; Dewar JA; Hawkins RA; Prescott RJ; George WD
    Br J Cancer; 1996 Jul; 74(2):297-9. PubMed ID: 8688340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.
    Aapro MS; Forbes JF
    Breast Cancer Res Treat; 2003; 80 Suppl 1():S3-11; discussion S13-8. PubMed ID: 14535530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.
    Blomqvist C; Tiusanen K; Elomaa I; Rissanen P; Hietanen T; Heinonen E; Gröhn P
    Br J Cancer; 1992 Dec; 66(6):1171-6. PubMed ID: 1457360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.
    Chlebowski RT; Haque R; Hedlin H; Col N; Paskett E; Manson JE; Kubo JT; Johnson KC; Wactawski-Wende J; Pan K; Anderson G
    Breast Cancer Res Treat; 2015 Dec; 154(3):609-16. PubMed ID: 26602222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer.
    Rutqvist LE; Cedermark B; Glas U; Johansson H; Rotstein S; Skoog L; Somell A; Theve T; Wilking N; Askergren J
    Cancer; 1990 Jul; 66(1):89-96. PubMed ID: 2191764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
    Azria D; Lemanski C; Zouhair A; Gutowski M; Belkacémi Y; Dubois JB; Romieu G; Ozsahin M
    Cancer Radiother; 2004 Jun; 8(3):188-96. PubMed ID: 15217586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cancer Research Campaign trials of adjuvant therapy for early breast cancer.
    Baum M; Ebbs SR; Houghton J; A'Hern RP; Riley D
    Acta Oncol; 1989; 28(6):907-12. PubMed ID: 2692654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.